Cellular and humoral systemic and mucosal immune responses stimulated in volunteers by an oral polybacterial immunomodulator "Dentavax"

International Immunopharmacology

Volumn 6, Issue 7, 2006, Pages 1181-1193

  Petrunov, Bogdan ^a   Marinova, Snejina ^a   Markova, Roumiana ^a   Nenkov, Plamen ^a   Nikolaeva, Sasha ^a   Nikolova, Maria ^a   Taskov, Hristo ^a   Cvetanov, Jordan ^a  

^a NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

Cell mediated immunity; Dentavax; Mucosal immunity; Oral immunization; Oral mucosa inflammation; Polybacterial immunomodulator

Indexed keywords

CD57 ANTIGEN; CD69 ANTIGEN; DENTAVAX; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; IMMUNOMODULATING AGENT; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; CANDIDA ALBICANS; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOPROPHYLAXIS; IN VITRO STUDY; INFLAMMATION; KLEBSIELLA PNEUMONIAE; LACTOBACILLUS ACIDOPHILUS; LYMPHOCYTE PROLIFERATION; MALE; MOUTH MUCOSA; NORMAL HUMAN; PERIODONTAL DISEASE; PERIPHERAL LYMPHOCYTE; PHAGOCYTE; PRIORITY JOURNAL; SALIVA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE ACTIVATION; ULTRASTRUCTURE;

ADMINISTRATION, ORAL; ADULT; ANTIBODIES, BACTERIAL; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; BACTERIA; BACTERIAL VACCINES; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNITY, NATURAL; IMMUNIZATION; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; PERIODONTAL DISEASES; PHAGOCYTOSIS; SALIVA; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 33646564958     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.02.012     Document Type: Article

References (64)

1. Loesche W.J. Bacterial mediators in periodontal disease. Clin Infect Dis 16 Suppl. 4 (1993) 203-210
2. Reviere G.R., Weisz K.S., Adams D.F., and Thomas D.D. Pathogen-related oral spirochetes from dental plaque are invasive. Infect Immun 59 10 (1991) 3377-3380
3. Kaldahl W.B., Kalkwarf K.L., and Patil K.D. A review of longitudinal studies that compared periodontal therapies. J Periodontol 64 4 (1993) 243-253
4. Gemmell E., Yamazaki K., Kjeldsen I., and Seymour G.J. Immunology of periodontal diseases. Mucosal Immunol Update 3 2 (1995) 4-11
5. Kaldahl W.B., Kalkwarf K.L., Patil K.D., Molvar M.P., and Dyer J. Long-term evaluation of periodontal therapy: I. Response to 4 therapeutic modalities. J Periodontol 67 2 (1996) 93-102
6. Danser M.M., Timmerman M.F., van Winkelhoff A.J., and van der Velden U. The effect of periodontal treatment on periodontal bacteria on the oral mucous membranes. J Periodontol 67 5 (1996) 478-485
7. Salvi G.E., and Lang N.P. Effect of non-steroid anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des 11 3 (2005) 1757-1769
8. Nieminen A., Asikainen S., Torkko H., Kari K., Uitto V.-J., and Saxen L. Value of some laboratory and clinical measurements in the treatment plan for advanced periodontitis. J Clin Periodontol 23 (1996) 572-581
9. Famili P., Cauley J., Suzuki J.B., and Weyant R. Longitudinal study of periodontal diseases and endentulism with rates of bone loss in older women. J Periodontol 76 1 (2005) 11-15
10. Evans R.T., Klausen B., Sojar H.T., Bedi G.S., Sfintescu C., Ramamurthy N.S., et al. Inmmunization with Porphyromanas (Bacteroides) gingivalas frimbriae protects against periodonatal destruction. Infect Immun 60 7 (1992) 2926-2935
11. Evans R.T., Klausen B., and Genco R.J. Immunization with protein and peptide protects against Porphyrompnas gingivalis induced periodontal tissue destruction. Adv Exp Med Biol 327 (1992) 255-262
12. Persson G.R., Engel L.D., Whitney C.W., Weinbeg A., Moncla B.J., Darveau R.P., et al. Macaca fascicularis as a model in which to assess the safety and efficacy of a vaccine for periodontitis. Oral Microbiol Immunol 9 (1994) 104-111
13. Page R.C. Vaccine development for periodontal diseases. Mucosal Immunol Update 3 2 (1995) 9-11
14. Boersma Wim J.A. Modulation of mucosal immunity by probiotic microorganisms. Mucosal Immunol Update 6 3 (1998) 5-6
15. Curtiss III R. Genetically modified plants for use as oral immunogens. Mucosal Immunol Update 7 1 (1999) 10-12
16. Page R.C. Vaccination and periodontitis: myth or reality. J Int Acad Periodontol 2 2 (2000) 31-41
17. DeCarlo A.A., Huang Y., Collyer C.A., Langley D.B., and Katz J. Fesibility of an HA2 domen-based periodontitis vaccine. Infect Immun 71 1 (2003) 562-566
18. Roberts F.A., Houston L.S., Lukehart S.A., Mancl L.A., Perssons G.R., and Page R.C. Periodontitis vaccine decreases local prostaglandin E2 level in a primate model. Infect Immun 72 2 (2004) 1166-1168
19. Asai Y., Jinno T., and Ogawa T. Oral treponemes and their outer membrane extracts activate human gingival epithelial cells through toll-like receptor 2. Infect Immun 71 2 (2003) 717-720
20. Petrunov B., Nenkov P., Marinova S., Cvetanov J., Konstantinova D., and Tchorbadjiiska L. A new peroral immunostimulator (polybacterial vaccine) for immunotherapy and immunoprophylaxis of nonspecific inflammations of oral mucosa and parodont-"Dentavax". Infectology, Sofia XX 2 (1993) 24-31 (in Bulgarian)
21. Nenkov P., Mitov I., Marinova S., and Markova R. Experimental Investigations on the immunomodulating activity of polybacterial preparation for per oral immunotherapy and immunoprophylaxis of uroinfections. Int J Immunopharmacol 7 6 (1995) 489
22. Markova R., Marinova S., Petrunov B., Cvetanov J., Nenkov P., Radinov A., et al. Stimulating effect of an oral polybacterial immunomodulator on the proliferative activity of guinea pig lymphocytes. In J Immunopharmacol 19 4 (1997) 205-214
23. Marinova S., Tchorbadjiiska L., Petrunov B., Cvetanov J., Nenkov P., Konstantinova D., et al. Immunostimulating and protective effects of an oral polybacterial immunomodulator "Dentavax" in a rabbit experimental model. Int J Immunopharmacol 22 (2000) 843-853
24. Taskov H., Petrunov B., Nenkov P., Marinova S., and Dimitrova E. The influence of the oral immunostimulator Dentavax on the phagocytic activity of PMNC in the peripheral blood of guinea pigs. Probl. Infect. Parasit. Dis. Sofia XXII (1995) 24-25
25. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scan Clin Lab Invest 21 Suppl. (1968) 77-89
26. Haffajee A., Socransky S.S., Taubman M., Sioson J., and Smith D.J. Patterns of antibody response in subjects with periodontitis. Oral Microbiol Immunol 10 (1995) 129-137
27. Grau A.J., Becher H., Ziegler ChM., Lichy Ch., Buggle F., Kaiser C., et al. Periodontal disease as a risk factor for ischemic stroke. Stroke 35 (2004) 496
28. Desvarieux M., Demmer R.T., Rundek T., Boden-Albala B., Jacobs Jr. D.R., Sacco R.L., et al. Periodontal microbiota and carotid intima-media thickness: the oral investigations and vascular diseases. Epidemiology Study (INVEST). Circulation 111 5 (2005) 576-582
29. Soder P.-O., Soder B., Novak J., and Jogestrand T. Early carotid atherosclerosis in subjects with periodontal diseases. Stroke 36 6 (2005) 1195-1200
30. Loe H., and Brown L.J. Early onset periodontal disease in the United States of America. J Periodontol 62 (1991) 608-616
31. Challacombe S.J., and Shirlaw P.J. Immunology of diseases of the oral cavity. In: Ogra P.L., and Mestecky J. (Eds) (1999), Academic Press Inc., San Diego 1313-1337
32. Challacombe S.J., Rahman D., Jeffery H., Davis S.S., and O'Hagan D.T. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology 76 (1992) 164-168
33. Cassone A., Chiani P., Quinty I., and Torosantucci A. Possible participation of polymorphonuclear cells stimulated by microbial immunomodulators in the dysregulated cytokine patterns of AIDS patients. J Leukoc Biol 62 1 (1997) 60-66
34. Mestecky J., Abraham R., and Ogra P.L. Common mucosal immune system and strategies for development of vaccines effective at the mucosal surfaces. In: Ogra P.L., Mestecky J., Lamm M.E., Strober W., McGhee J.R., Bienenstock J., and McChee J.R. (Eds). Handbook of mucosal immunology (1994), Academic Press Inc., San Diego 357-372
35. Mouynet P., Picot C., Nicolas P., Genetet B., Apiou, Genetet N., et al. Ex vivo studies of polymorphonuclear neutrophils from patients with early-onset periodontitis. III. CR3 and LFA-1 expression by peripheral blood and gingival crevicular polymorphonuclear neutrophils. J Clin Periodontol 22 (1995) 110-117
36. Wasenaar A. T cells and fibroblasts in chronic adult periodontitis (1998), Academisch Proefchrift, University of Amsterdam, The Netherlands 93
37. Hadden E.M., Sosa W.Y.M., Coffey R.G., Giner-Sorolla A., and Hadden J.W. Methyl inosine monophosphate (MIMP) augments T-lymphocyte mitogen responses and reverses various immunosuppressants. Int J Immunopharmacol 17 9 (1995) 763-770
38. Martinelli F., Corulli M., Dima F., Fallacara F., Savio L., Jing G., et al. Heat-killed Bacillus subtilis inhibits T-cell proliferative response to mitogens and recall antigens. Int J Immunopharmacol 18 12 (1996) 701-706
39. Hoffmann P., Mittenbuhler K., Bessler W.G., Heinevetter L., Wiesmuller K.-H., Jung G., et al. Bacterial cell wall components as immunomodulators-I. Lipopeptides as adjuvants for parenteral and oral immunization. Int J Immunopharmacol 19 9-10 (1997) 547-550
40. Wendling U., Bloemendal A., Van Der Zee R., Rutten V.P.M.G., Van Kooten P.J.S., Farine J.C., et al. Antirheumatic E. coli extract OM-89 induces T cell responses to hsp60 and 70. Int J Immunopharmacol 19 9 (1997) 565-568 4
41. Van Pham T., Kreis B., Corradin-Betz S., Bauer J., and Mauel J. Metabolitic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies. J Biol Response Modif 9 (1990) 231
42. Huber M., Ayoub M., Pfannes S.D.C., Mittenbühler K., Weis K., Bessler W.G., et al. Immunostimulatory activity of the bacterial extract OM-89. Eur J Med Res 5 (2000) 101-109
43. Testerman T.L., Gerster J.F., Imbertson L.M., Reiter M.J., Miller R.L., Gibson S.J., et al. Cytokine induction by the immunomodulators imiquimod and S-27609. J Leukoc Biol 58 (1995) 365
44. Gibson S.J., Imbertson L.M., Wagner T.L., Testerman T.L., Reiter M.J., and Miller R.L. Cellular requirements for cytokine production in response to the immunomodulators imiquimod and S-27609. J Interferon Cytokine Res 15 6 (Jun 1995) 537-545
45. Gibson S.J., Lindh J.M., Riter T.R., Gleason R.M., Rogers L.M., Fuller A.E., et al. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cell Immunol 218 1-2 (Jul-Aug 2002) 74-86
46. - dendritic cells. J Immunol 171 (2003) 1156-1163
47. Van Parijs L., Refaeli Y., Lord J.D., Nelson B.H., Abbas A.K., and Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival and Fas-mediated activation-induced cell death. Immunity 11 3 (Sep 1999) 281-288
48. Deenick E.K., Gett A.V., and Hodgkin P.D. Stochastic model of T cell proliferation: a calculus revealing IL-2 regulation of precursor frequencies, cell cycle time, and survival. J Immunol 170 (2003) 4963-4972
49. Hafstrom C.A., Wikstrom M.B., Renvert S.N., and Dahlen G.G. Effect of treatment on some periodontopathogens and their antibody levels in periodontal abscesses. J Periodontol 65 11 (1994) 1022-1028
50. Katz J., Harmon C.C., Buckner G.P., Richardson G.J., Russell M.W., and Michalek S.M. Protective salivary Immunoglobulin A responses against Streptococcus mutans infection after intranasal immunization with S. mutans antigen I/II coupled to the B subunit of Cholera toxin. Infect Immun 61 5 (1993) 1964-1971
51. Widerstrom L., Bratthall D., and Hamberg K. Immunoglobulin A antibodies to mutans streptococci in human saliva and serum comparing fresh and subcultivated strains and activity in repeated saliva samples. Oral Microbiol Immunol 9 (1994) 278-283
52. Brandtzaeg P., Baekkevold E.S., Fastard I.N., Jahnsen F.L., Johansen F.E., Nilsen E.M., et al. Regional specialization in the mucosal immune system; what happens in the microcompartments?. Immunol Today 20 3 (1999) 141-151
53. Kuper C.F., Koornstra P.J., Hameleers D.M.H., Biewenga J., van Breda Vriesman P.J.C., and Sminia T. The role of nasopharyngeal lymphoid tissue. Immunol Today 13 6 (1992) 219-224
54. Perry M., and White A. Immunology of the tonsils. Immunol Today 19 9 (1998) 414-420
55. Bienenstock J., and Befus A.D. Mucosal immunology. Immunology 41 (1980) 249-270
56. Brandtzaeg P., and Hanenberg B. Role of nasal associated lymphoid tissue in the humoral mucosal immune system. Mucosal Immunol Update 5 1 (1997) 4-8
57. Nenkov P. Overview on the clinical studies with Urostim-immunostimulator against urogenital infections. In: Emody, et al. (Ed). Genes and proteins underlying microbial urinary tract virulence (2000), Kluwer Academic Plenum Publisher 325 pp.
58. Marinova S., Nenkov P., Markova R., Nikolaeva S., Kostadinova R., Mitov I., et al. Cellular and humoral systemic and mucosal immune responses stimulated by an oral polybacterial immunomodulator in patients with chronic urinary tract infections. Int J Immunopathol Pharmacol 18 3 (2005) 457-473
59. Freudenberg M.A., Fomsgaard A., Mitov I., and Calanos C. ELISA for antibodies to A. Lipid, lipopolysaccharides and other hydrophobic antigens. Infection 17 5 (1989) 322-328
60. Freudenberg M.A., and Galanos C. Tumour necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in d-galactosamine-treated mice. Infect Immun 59 (1991) 2110
61. Tonetti M.S., Imboden M.A., Gerber L., Lang N.P., Laissue J., and Mueller Ch. Localized expression of mRNA for phagocyte-specific chemotactic cytokines in human periodontal infections. Infect Immun 62 9 (1994) 4005-4014
62. Sparwasser T., Miethke T., Lipford G., Borschert K., Hacker H., Heeg K., et al. Bacterial DNA causes septic shock. Nature 386 (1997) 336
63. Holmgren J., and Czerkinsky C. Mucosal immunity and vaccines. Nat Med Vaccines (Suppl) 11 4 (2005) S45-S53
64. Pashine A., Valiante N.M., and Ulmer J.B. Targeting the innate immune response with improved vaccine adjuvants. Nat Med Vaccines (Suppl) 11 4 (2005) S63-S68